Clarity Financial’s OptiNose OPTN Stock Holding History

Clarity Financial’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-966	Closed	-$43K	–	114
2021 Q3	$43K	Hold	966	–	–	0.01%	95
2021 Q2	$45K	Buy	+966	New	+$49.3K	0.01%	109

Other funds holding OPTN

MPU

MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Clarity Financial's OPTN Position: Q4 2021 in Review

Clarity Financial sold out of OptiNose (OPTN) in Q4 2021, closing a stake of 966 shares — an estimated $43K sold.

Clarity Financial first reported a position in OPTN in Q2 2021 and held it in 2 quarters. The position peaked at $45K in Q2 2021. 44 funds tracked by Wall St. Rank hold OPTN as of Q4 2021.

Clarity Financial reported no remaining OptiNose position as of Q4 2021 after selling out during the quarter.
Clarity Financial sold 966 OptiNose shares in Q4 2021, an estimated $43K.
Clarity Financial first reported a position in OptiNose in Q2 2021 and held it in 2 quarters.
Clarity Financial's OptiNose position peaked at $45K in Q2 2021.
44 funds tracked by Wall St. Rank held OptiNose as of Q4 2021.

Based on Clarity Financial's 13F filing for Q4 2021, filed 4 Feb 2022.